[The effectiveness of the new corticoid A 41 304. Evaluation by means of a graphic presentation].
In an intra-individual, symetrical comparative study, the efficacy of a new corticoid of external use-A 41 304- was compared to that of a preparation of reknown effect. Fluocinolon-acetonide. The treatment included 25 patients with bilateral symetrical lesions of Psoriasis, in their majority of prolonged, continuous and not regressive development. Furthermore, the study included 13 patients with eczematoid dermatits. A graphic method of evaluation was employed, which permitted an integrated study of the intensity, the rapidity and the duration of the morbistatic effect of the preparations. Under the conditions of the clinical experimentation which were applied, the new preparation (A 41 304) proved to be more effective than Fluocinolone-acetonide. The characteristics of the new graphic method of evaluation are discussed.
D000293:Adolescent; D000328:Adult; D002648:Child; D003872:Dermatitis / Q000188:drug therapy; D003907:Dexamethasone / Q000031:analogs & derivatives* / Q000627:therapeutic use; D004341:Drug Evaluation / Q000379:methods; D004485:Eczema / Q000188:drug therapy; D005260:Female; D005446:Fluocinolone Acetonide / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011565:Psoriasis / Q000188:drug therapy
D005446:Fluocinolone Acetonide; D003907:Dexamethasone
Die Wirksamkeit des neuen Kortikoids A 41 304 Auswertung mit Hilfe einer graphischen Darstellung